Assert Therapeutics Llp Profile
Key Indicators
- Obligation of Contribution ₹ 0.60 M
- Company Age 7 Year, 2 Months
- Last Filing with ROC 31 Mar 2019
About Assert Therapeutics Llp
Assert Therapeutics Llp (ATL) is 7 Year, 2 Months old Limited Liability Partnership 22 November 2017. Its registered office is in .
The LLP status is Active, and it has filed its Accounts and Solvency Statement up to 31 Mar 2019 (FY 2018-2019). It's Total Obligation of Contribution is Rs 0.60 M as per MCA.
Company Details
-
Location
-
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN/FCRN
AAL-2124
-
Incorporation Date
22 Nov 2017
-
Date of Accounts and Solvency Statement
31 Mar 2019
-
ROC Code
Roc-Ahmedabad
-
Company Classification
Limited Liability Partnership
Industry
Who are the key members and board of directors at Assert Therapeutics Llp?
Designated Partners (6)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Mohammedasif Mubarack
![]() |
Designated Partner | 22-Nov-2017 | Current |
Senthilkumar Ramu
![]() |
Designated Partner | 22-Nov-2017 | Current |
Solamuthu Gandhi
![]() |
Designated Partner | 22-Nov-2017 | Current |
Pillai Tamilmani
![]() |
Designated Partner | 22-Nov-2017 | Current |
Jayaraman Thennavan
![]() |
Designated Partner | 22-Nov-2017 | Current |
Dharman Radha
![]() |
Designated Partner | 22-Nov-2017 | Current |
Financial Performance of Assert Therapeutics Llp.
Enhance accessibility to Assert Therapeutics Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
![Graph illustrating revenue growth over time](/Images/financial/revenue-growth.webp)
![Graph showing profit and loss trends over time](/Images/financial/profit-loss.webp)
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Assert Therapeutics Llp?
Unlock access to Assert Therapeutics Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
![Shareholding Indicator graph](/Images/tcc-login/Shareholding-Indiacator-1200.webp)
Charges (Loans)
![Placeholder for charges-related data](/Images/tcc-no-data-images/Charges.webp)
There are no Open Charges registered against the LLP as per our records.
How Many Employees Work at Assert Therapeutics Llp?
Unlock and access historical data on people associated with Assert Therapeutics Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
![Graph showing employee growth trends](/Images/tcc-login/Employee-Graph.webp)
Deals i
![Graph showing company valuation over time](/Images/tcc-login/Valuation-Graph-small.webp)
Gain comprehensive insights into the Deals and Valuation data of Assert Therapeutics Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Assert Therapeutics Llp's trajectory.
Rating
![Graph displaying rating trends over time](/Images/tcc-login/Rating-Graph-small.webp)
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
![Alert Indicator](/Images/tcc-login/Alert-Indicator-small.webp)
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.